Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Park Hotels & Resorts Inc. Common Stock (PK) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Park Hotels & Resorts Inc. Common StockTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Park Hotels & Resorts Inc. Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Park Hotels & Resorts Inc. Common Stock trades at $15.12 (market cap $3.14B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 3.4× Park Hotels & Resorts Inc. Common Stock's market cap, and Park Hotels & Resorts Inc. Common Stock pays the higher dividend (6.41%). Which is the better fit depends on your goals — on Pluang, investors hold Park Hotels & Resorts Inc. Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

PKRDY
Market Cap
$3.14B$10.78B
Volume
3,553,9852,724,343
Sector
Real EstateHealth
52-Week High
$16.17$15.38
52-Week Low
$9.84$11.38
Typical Hold Time
0 Days0 Days
Enterprise Value
$6.98B$10.68B
Dividend Yield
6.41%0.65%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PK
100% Buy0% Sell
Avg holding period · 0 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

About Park Hotels & Resorts Inc. Common Stock

Park Hotels & Resorts Inc. is a US lodging REIT, spun off from Hilton Worldwide in 2017, that owns a portfolio of premium-branded hotels and resorts in major urban, resort, and convention markets.

Read more on PK →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →